138 related articles for article (PubMed ID: 38266181)
1. Engineering an Autonucleolytic Mammalian Suspension Host Cell Line to Reduce DNA Impurity Levels in Serum-Free Lentiviral Process Streams.
Howe G; Wasmuth M; Emanuelle P; Massaro G; Rahim AA; Ali S; Rivera M; Ward J; Keshavarz-Moore E; Mason C; Nesbeth DN
ACS Synth Biol; 2024 Feb; 13(2):466-473. PubMed ID: 38266181
[TBL] [Abstract][Full Text] [Related]
2. Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene.
Ali S; Rivera M; Ward J; Keshavarz-Moore E; Mason C; Nesbeth DN
Heliyon; 2023 Jun; 9(6):e17067. PubMed ID: 37484388
[TBL] [Abstract][Full Text] [Related]
3. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
4. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment.
Sastry L; Xu Y; Cooper R; Pollok K; Cornetta K
Hum Gene Ther; 2004 Feb; 15(2):221-6. PubMed ID: 14975194
[TBL] [Abstract][Full Text] [Related]
6. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures.
Vaz TA; Rodrigues AF; Coroadinha AS
Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159
[TBL] [Abstract][Full Text] [Related]
7. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
Ogueta SB; Yao F; Marasco WA
Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
[TBL] [Abstract][Full Text] [Related]
8. Generation of stable suspension producer cell lines for serum-free lentivirus production.
Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
Do Minh A; Tran MY; Kamen AA
Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669
[TBL] [Abstract][Full Text] [Related]
10. A robust transfection reagent for the transfection of CHO and HEK293 cells and production of recombinant proteins and lentiviral particles - PTG1.
Gonçalves C; Gross F; Guégan P; Cheradame H; Midou P
Biotechnol J; 2014 Nov; 9(11):1380-8. PubMed ID: 25215936
[TBL] [Abstract][Full Text] [Related]
11. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
12. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells.
Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K
Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755
[TBL] [Abstract][Full Text] [Related]
13. Production of lentiviral vectors for transducing cells from the central nervous system.
Li M; Husic N; Lin Y; Snider BJ
J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
[TBL] [Abstract][Full Text] [Related]
14. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
15. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.
Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE
Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741
[TBL] [Abstract][Full Text] [Related]
16. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
17. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature.
Yang T; Burrows C; Park JH
Plasmid; 2014 Mar; 72():29-35. PubMed ID: 24727543
[TBL] [Abstract][Full Text] [Related]
18. A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cells.
Bryson PD; Zhang C; Lee CL; Wang P
J Vis Exp; 2013 Jun; (76):. PubMed ID: 23851977
[TBL] [Abstract][Full Text] [Related]
19. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
Mitta B; Rimann M; Fussenegger M
Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of lentivirus containing human FcγRIIB gene and FcγRIIB expression in HT-1080 cells].
Liu H; Cao X; Yang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):561-4, 568. PubMed ID: 24909272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]